Rezvan Najafi

3.7k total citations · 1 hit paper
122 papers, 2.7k citations indexed

About

Rezvan Najafi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Rezvan Najafi has authored 122 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 31 papers in Cancer Research and 25 papers in Oncology. Recurrent topics in Rezvan Najafi's work include MicroRNA in disease regulation (20 papers), Cancer-related molecular mechanisms research (10 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Rezvan Najafi is often cited by papers focused on MicroRNA in disease regulation (20 papers), Cancer-related molecular mechanisms research (10 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Rezvan Najafi collaborates with scholars based in Iran, Denmark and United States. Rezvan Najafi's co-authors include Massoud Saidijam, Fatemeh Karimi Dermani, Pouria Samadi, Razieh Amini, Saeid Afshar, Ali Mohammad Sharifi, Hamed Manoochehri, Nashmin Fayazi Hosseini, Sara Soleimani Asl and Asieh Hosseini and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gene and Life Sciences.

In The Last Decade

Rezvan Najafi

115 papers receiving 2.7k citations

Hit Papers

PD‐1/PD‐L1 immune checkpoint: Potential target for cancer... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. PD‐1/PD‐L1 immune checkpoint: Potential target for cancer therapy
    2018 368 citations Fatemeh Karimi Dermani, Pouria Samadi et al. Journal of Cellular Physiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rezvan Najafi Iran 27 1.3k 680 540 268 222 122 2.7k
Ana Bela Sarmento‐Ribeiro Portugal 30 1.5k 1.2× 743 1.1× 729 1.4× 302 1.1× 351 1.6× 130 3.2k
Min Xiao China 24 1.6k 1.2× 601 0.9× 624 1.2× 314 1.2× 208 0.9× 73 3.0k
Song Iy Han South Korea 30 1.6k 1.3× 721 1.1× 837 1.6× 326 1.2× 269 1.2× 75 2.9k
Silvia Zappavigna Italy 35 1.7k 1.4× 856 1.3× 805 1.5× 304 1.1× 366 1.6× 100 3.6k
Min Young Lee South Korea 30 1.6k 1.3× 479 0.7× 293 0.5× 346 1.3× 163 0.7× 110 2.6k
Zakaria Y. Abd Elmageed United States 31 1.6k 1.3× 824 1.2× 583 1.1× 324 1.2× 335 1.5× 94 2.9k
Hu Chen China 33 2.0k 1.6× 953 1.4× 939 1.7× 308 1.1× 218 1.0× 176 3.7k
Yingjie Zhang China 38 2.6k 2.0× 730 1.1× 811 1.5× 292 1.1× 213 1.0× 194 4.1k

Countries citing papers authored by Rezvan Najafi

Since Specialization
Citations

This map shows the geographic impact of Rezvan Najafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rezvan Najafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rezvan Najafi more than expected).

Fields of papers citing papers by Rezvan Najafi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rezvan Najafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rezvan Najafi. The network helps show where Rezvan Najafi may publish in the future.

Co-authorship network of co-authors of Rezvan Najafi

This figure shows the co-authorship network connecting the top 25 collaborators of Rezvan Najafi. A scholar is included among the top collaborators of Rezvan Najafi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rezvan Najafi. Rezvan Najafi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mehrabani, Mehrnaz, et al.. (2024). Rheum khorasanicum Decreases Migration and Induces Apoptosis in the MDA-MB-231 Breast Cancer Cell Line. Letters in Drug Design & Discovery. 21(17). 3812–3822. 2 indexed citations
2.
Mahdavinezhad, Ali, Rezvan Najafi, Saeid Afshar, et al.. (2023). Highlighting functions of apoptosis and circular RNAs in colorectal cancer. Pathology - Research and Practice. 248. 154592–154592. 4 indexed citations
3.
4.
Najafi, Rezvan, et al.. (2023). A dual chemiluminescence and ratiometric fluorescence sensor based on WS2 QDs- Fe(II)- S2O82− system for bisphenol A detection. Optical Materials. 144. 114320–114320. 9 indexed citations
5.
Tapak, Leili, et al.. (2023). Identification of key genes in colorectal cancer diagnosis by weighted gene co-expression network analysis. Computers in Biology and Medicine. 157. 106779–106779. 27 indexed citations
6.
Najafi, Rezvan, et al.. (2021). A promising effect of zerumbone with improved anti-tumor-promoting inflammation activity of miR-34a in colorectal cancer cell lines. Molecular Biology Reports. 48(1). 203–218. 7 indexed citations
7.
Bahreini, Fatemeh, et al.. (2021). The Combination of Zerumbone and 5‐FU: A Significant Therapeutic Strategy in Sensitizing Colorectal Cancer Cells to Treatment. BioMed Research International. 2021(1). 7 indexed citations
8.
Soheilifar, Mohammad Hasan, Majid Pornour, Massoud Saidijam, et al.. (2021). miR-1290 contributes to oncogenesis and angiogenesis via targeting of THBS1, DKK3 and, SCAI. Bioimpacts. 12(4). 349–358. 14 indexed citations
9.
Bahreini, Fatemeh, et al.. (2021). Assessment of lncRNA DANCR, miR-145-5p and NRAS axis as biomarkers for the diagnosis of colorectal cancer. Molecular Biology Reports. 48(4). 3541–3547. 12 indexed citations
10.
Tanzadehpanah, Hamid, Hanie Mahaki, Mohammadreza Moradi, et al.. (2020). The Use of Molecular Docking and Spectroscopic Methods for Investigation of The Interaction Between Regorafenib with Human Serum Albumin (HSA) and Calf Thymus DNA (Ct-DNA) In The Presence Of Different Site Markers. Protein and Peptide Letters. 28(3). 290–303. 8 indexed citations
11.
Bahreini, Fatemeh, et al.. (2020). Reducing False Negative PCR Test for COVID-19. SHILAP Revista de lepidopterología. 9(3). 408–410. 24 indexed citations
12.
13.
Saidijam, Massoud, et al.. (2018). Assessment of CEP55, PLK1 and FOXM1 expression in patients with bladder cancer in comparison with healthy individuals. Cancer Investigation. 36(8). 407–414. 13 indexed citations
14.
Samadi, Pouria, Saeid Afshar, Razieh Amini, et al.. (2018). Let‐7e enhances the radiosensitivity of colorectal cancer cells by directly targeting insulin‐like growth factor 1 receptor. Journal of Cellular Physiology. 234(7). 10718–10725. 41 indexed citations
15.
Dermani, Fatemeh Karimi, et al.. (2016). Resveratrol Inhibits Proliferation, Invasion, and Epithelial–Mesenchymal Transition by Increasing miR‐200c Expression in HCT‐116 Colorectal Cancer Cells. Journal of Cellular Biochemistry. 118(6). 1547–1555. 75 indexed citations
16.
Sheikh, Nasrin, et al.. (2008). Correlation between sperm parameters and sperm DNA fragmentation in fertile and infertile men. International Journal of Reproductive BioMedicine (IJRM). 6(1). 13–18. 33 indexed citations
17.
Najafi, Rezvan, et al.. (2008). Preparation of prostate specific antigen standards for immunoradiometric assay. Iranian Journal of radiation research. 6(1). 51–58. 1 indexed citations
18.
Najafi, Rezvan, et al.. (2006). Synthesis, development and preclinical comparison of two new peptide based freeze-dried kit formulation 99m Tc-EDDA-Tricine-HYNIC-TOC and 99m Tc-EDDA-Tricine-HYNIC-TATE for somatostatin receptor positive tumor scintigraphy. DARU Journal of Pharmaceutical Sciences. 14(4). 183–189. 7 indexed citations
19.
Amiri, Iraj, et al.. (2006). NITRIC OXIDE LEVEL IN SEMINAL PLASMA OF FERTILE AND INFERTILE MALES AND ITS CORRELATION WITH SPERM PARAMETERS. DARU Journal of Pharmaceutical Sciences. 14(4). 197–202. 11 indexed citations
20.
Salouti, Mojtaba, et al.. (2006). A NEW MONOCLONAL ANTIBODY RADIOPHARMACEUTICAL FOR RADIOIMMUNOSCINTIGRAPHY OF BREAST CANCER: DIRECT LABELING OF ANTIBODY AND ITS QUALITY CONTROL. DARU Journal of Pharmaceutical Sciences. 14(1). 51–56. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana Bela Sarmento‐Ribeiro Breakdown of academic impact, for papers by Min Xiao Breakdown of academic impact, for papers by Song Iy Han Breakdown of academic impact, for papers by Silvia Zappavigna Breakdown of academic impact, for papers by Min Young Lee Breakdown of academic impact, for papers by Zakaria Y. Abd Elmageed Breakdown of academic impact, for papers by Hu Chen Breakdown of academic impact, for papers by Yingjie Zhang
Rankless by CCL
2026